|
[Related PubMed/MEDLINE] Total Number of Papers: 40
|
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of |
|
|
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2018 |
Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol. |
ANGPTL3, apo, HDL-C, LDL-C, LDLR, TG |
2 |
2017 |
Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies. |
AD, LDLR |
3 |
2017 |
Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9. |
LDLR, PCSK9, VLDLR |
4 |
2014 |
Scavenger receptor class B, type I (Scarb1) deficiency promotes osteoblastogenesis but stunts terminal osteocyte differentiation. |
AXIN2, CE, DKK1, DMP1, HDL, Lef1, MSC, SOST, SR-BI, WT |
5 |
2012 |
The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain. |
AD, APOE, DA, GFAP, LDLR, MPTP, PD |
6 |
2010 |
Atorvastatin increases expression of low-density lipoprotein receptor mRNA in human circulating mononuclear cells. |
HMGCR, LDL |
7 |
2009 |
Low pH-triggered beta-propeller switch of the low-density lipoprotein receptor assists rhinovirus infection. |
HRVs, LDLR, VLDLR, WT |
8 |
2007 |
LDL-receptor mRNA expression in men is downregulated within an hour of an acute fat load and is influenced by genetic polymorphism. |
BA, HMGCR, LDL-C, LDLR, mRNA |
9 |
2006 |
Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in mice. |
APOC1, LDLR, LPL, TG, VLDL-R |
10 |
2006 |
Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes. |
APOE, LDLR |
11 |
2006 |
Interaction of beta2-glycoprotein I with members of the low density lipoprotein receptor family. |
APS, beta2GPI, LDLR, VLDL-R |
12 |
2006 |
LRP in amyloid-beta production and metabolism. |
AD, APOE, APP, CNS, LDLR |
13 |
2005 |
LDL receptor cooperates with LDL receptor-related protein in regulating plasma levels of coagulation factor VIII in vivo. |
FVIII, LDL, RAP |
14 |
2003 |
Ca2+ binding to complement-type repeat domains 5 and 6 from the low-density lipoprotein receptor-related protein. |
CR, LDLR |
15 |
2003 |
Modulation of the LDL receptor and LRP levels by HIV protease inhibitors. |
HIV, LDLR |
16 |
2002 |
Second cysteine-rich domain of Dickkopf-2 activates canonical Wnt signaling pathway via LRP-6 independently of dishevelled. |
Dkk, Dvl, LEF |
17 |
2002 |
The effects of chylomicron remnants enriched in n-3 or n-6 polyunsaturated fatty acids on the transcription of genes regulating their uptake and metabolism by the liver: influence of cellular oxidative state. |
LDLR, NAC, PUFA |
18 |
2002 |
Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice. |
apo, LDLR, PUFA, SREBP-1 |
19 |
2001 |
Apolipoprotein E and apolipoprotein E receptors modulate A beta-induced glial neuroinflammatory responses. |
AD, APOE, apoE, db, LDLR, LPS, RAP |
20 |
2001 |
Differential functions of members of the low density lipoprotein receptor family suggested by their distinct endocytosis rates. |
ApoER2, LDLR, VLDLR |
21 |
2001 |
Dominant thermodynamic role of the third independent receptor binding site in the receptor-associated protein RAP. |
CR, LDLR, RAP |
22 |
2001 |
Expression and regulation of apolipoprotein E receptors in the cells of the central nervous system in culture: A review. |
APOE, ApoER2, CNS, LDLR, VLDLR |
23 |
2001 |
LDL receptor-related protein mediates cell-surface clustering and hepatic sequestration of chylomicron remnants in LDLR-deficient mice. |
HSPGs, LDLR-deficient |
24 |
2001 |
Lipoprotein lipase mediates the uptake of glycated LDL in fibroblasts, endothelial cells, and macrophages. |
apo, gLDL, LDLR, LPL |
25 |
2001 |
Postprandial lipoproteins and atherosclerosis. |
CHD, HSPG, LDLR |
26 |
2000 |
Apolipoprotein E receptors mediate the effects of beta-amyloid on astrocyte cultures. |
APOE, LDLR |
27 |
1999 |
An extrahepatic receptor-associated protein-sensitive mechanism is involved in the metabolism of triglyceride-rich lipoproteins. |
LDLR, LPL, RAP, VLDL |
28 |
1999 |
Evaluation of the components of the chylomicron remnant removal mechanism by use of the isolated perfused mouse liver. |
LDLRD, RAP |
29 |
1999 |
Identification of a LDL-receptor in the lymphatic filarial parasiteWuchereria bancrofti. |
--- |
30 |
1999 |
Identification of megalin/gp330 as a receptor for lipoprotein(a) in vitro. |
DiI, GP, LDLR |
31 |
1999 |
Upregulation of selective cholesteryl ester uptake pathway in mice with deletion of low-density lipoprotein receptor function. |
HDL, LDLR |
32 |
1998 |
Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor. |
BMT, LDLR |
33 |
1998 |
Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice. |
LDLR, RAP |
34 |
1998 |
Molecular cloning and characterization of LR3, a novel LDL receptor family protein with mitogenic activity. |
LDLR |
35 |
1997 |
[Lipoprotein receptors. Old acquaintances and newcomers]. |
HDLR, LSR, SR, VLDLR |
36 |
1995 |
gp330 on type II pneumocytes mediates endocytosis leading to degradation of pro-urokinase, plasminogen activator inhibitor-1 and urokinase-plasminogen activator inhibitor-1 complex. |
gp330, LDLR |
37 |
1995 |
Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1. |
LDLR, RAP, SMCs, TSP-1 |
38 |
1995 |
Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. |
LDL, RAP |
39 |
1994 |
Complete cloning and sequencing of rat gp330/"megalin," a distinctive member of the low density lipoprotein receptor gene family. |
LDLR |
40 |
1989 |
Lipoprotein binding and endosomal itinerary of the low density lipoprotein receptor-related protein in rat liver. |
LDLR |
|